Register
Medicines reference
Product

Felocell 3

Feline herpesvirus + Feline calicivirus + Feline parvovirus · Zoetis Inc.

1 form: suspension. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
Suspension · Cat Cat 1 ml (1 ml)
Reconstitute with the supplied diluent and administer one 1 ml dose to healthy cats 12 weeks or older. Give two doses 3-4 weeks apart; when starting before 16 weeks, give the final dose no earlier than 16 weeks. Duration of immunity and annual booster need are not established on the current label. Do not use in pregnant animals. Anaphylaxis may occur; initial epinephrine followed by supportive therapy is recommended. Store at 2-8 C, protect from heat and sunlight, do not freeze, and do not mix except as specified. Incubating disease, malnutrition, parasitism, stress or immunocompromise may reduce the response.
· two doses 3-4 weeks apart; later boosters by veterinary consultation
two doses 3-4 weeks apart; later boosters by veterinary consultation Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ფელოცელი 3 - კატის ვირუსული რინოტრაქეიტის, კალცივირუსით გამოწვეულლი რესპირატორული დაავადებისა და პარვოვირუსით გამოწვეული პანლეიკოპენიის საწინააღმდეგო ცოცხალი ვირუს ვაქცინა, გამხსნელით
№ 301-11
Verified on: 21 Oct 2026
Suspension · Cat Cat 1 ml (1 ml)
Reconstitute with the supplied diluent and administer one 1 ml dose to healthy cats 12 weeks or older. Give two doses 3-4 weeks apart; when starting before 16 weeks, give the final dose no earlier than 16 weeks. Duration of immunity and annual booster need are not established on the current label. Do not use in pregnant animals. Anaphylaxis may occur; initial epinephrine followed by supportive therapy is recommended. Store at 2-8 C, protect from heat and sunlight, do not freeze, and do not mix except as specified. Incubating disease, malnutrition, parasitism, stress or immunocompromise may reduce the response.
· two doses 3-4 weeks apart; later boosters by veterinary consultation
two doses 3-4 weeks apart; later boosters by veterinary consultation Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ფელოცელი 3 - კატის ვირუსული რინოტრაქეიტის, კალცივირუსით გამოწვეულლი რესპირატორული დაავადებისა და პარვოვირუსით გამოწვეული პანლეიკოპენიის საწინააღმდეგო ცოცხალი ვირუს ვაქცინა, გამხსნელით
№ 301-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Felocell 3, Suspension

lyophilisate and diluent, 1 ml dose for cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
8.1/10
Very good
vetman assessment

Felocell 3

lyophilisate and diluent, 1 ml dose for cats
Assessed clinical scopeCat · Full cat label from 12 weeks: live FHV-1, FCV and FPV core immunisation · SC,IM
Care settingPreventive veterinary vaccination of a healthy cat with examination and cold-chain control
vetman score 8.1/10 Very good
Evidence confidence: Medium Georgia: Yes, veterinary · № 301-11 · Verified on 21 Oct 2026

A very good live trivalent core vaccine for cats. Finish the kitten series at 16 weeks or later and boost by WSAVA or AAHA/AAFP intervals.

Regulatory and scientific credibility8.0/10

The exact product is registered in Georgia (301-11), and the attenuated trivalent formulation is documented in a current Zoetis label; the Felocell trade name has no major-regulator dossier and the register entry gives no antigen titres.

Clinical efficacy8.5/10

These are the three worldwide feline core antigens: live FPV gives robust protection and FHV-1/FCV vaccination reduces disease though not infection.

Safety and tolerability8.0/10

Live trivalent cat vaccines have a favourable profile in healthy cats; anaphylaxis is rare, and live FPV must not be given to pregnant queens.

Clinical practicality8.0/10

Two 1 ml doses 3-4 weeks apart, the last at 16 weeks or later, and guideline-based boosting are routine and simple.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in pregnant queens. Vaccinate only healthy cats.
  • Anaphylaxis is rare but possible: keep epinephrine and supportive treatment ready.
  • When starting before 16 weeks, give the final dose no earlier than 16 weeks of age; maternal antibody can block earlier doses.
  • FHV-1 and FCV vaccination reduces disease but does not prevent infection or carrier state.
  • Incubating disease, malnutrition, parasites, stress or immunosuppression can reduce the response.
  • Store at 2-8 C away from heat and sunlight, do not freeze and do not mix except as specified.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Feline herpesvirus Feline calicivirus Feline parvovirus
Formulation Type
Suspension
Administration route
Subcutaneous, Intramuscular
Manufacturer
Zoetis Inc. · United States
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ფელოცელი 3 - კატის ვირუსული რინოტრაქეიტის, კალცივირუსით გამოწვეულლი რესპირატორული დაავადებისა და პარვოვირუსით გამოწვეული პანლეიკოპენიის საწინააღმდეგო ცოცხალი ვირუს ვაქცინა, გამხსნელით
№ 301-11
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml (1 ml)
Reconstitute with the supplied diluent and administer one 1 ml dose to healthy cats 12 weeks or older. Give two doses 3-4 weeks apart; when starting before 16 weeks, give the final dose no earlier than 16 weeks. Duration of immunity and annual booster need are not established on the current label. Do not use in pregnant animals. Anaphylaxis may occur; initial epinephrine followed by supportive therapy is recommended. Store at 2-8 C, protect from heat and sunlight, do not freeze, and do not mix except as specified. Incubating disease, malnutrition, parasitism, stress or immunocompromise may reduce the response.
Cat Any weight Subcutaneous two doses 3-4 weeks apart; later boosters by veterinary consultation
Zoetis label 2026
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Vanguard Feline RCP (formerly Felocell 3 RCP) - official package insert
Zoetis package insert, 2026
1 ml (1 ml)
Reconstitute with the supplied diluent and administer one 1 ml dose to healthy cats 12 weeks or older. Give two doses 3-4 weeks apart; when starting before 16 weeks, give the final dose no earlier than 16 weeks. Duration of immunity and annual booster need are not established on the current label. Do not use in pregnant animals. Anaphylaxis may occur; initial epinephrine followed by supportive therapy is recommended. Store at 2-8 C, protect from heat and sunlight, do not freeze, and do not mix except as specified. Incubating disease, malnutrition, parasitism, stress or immunocompromise may reduce the response.
Cat Any weight Intramuscular two doses 3-4 weeks apart; later boosters by veterinary consultation
Zoetis label 2026
Manufacturer material
Information published by the maker or a seller, such as a datasheet or product page. A medicines regulator has not necessarily reviewed it.
Vanguard Feline RCP (formerly Felocell 3 RCP) - official package insert
Zoetis package insert, 2026

Feline herpesvirus: No dose supported by a publicly verifiable source yet

Feline calicivirus: No dose supported by a publicly verifiable source yet

Feline parvovirus: No dose supported by a publicly verifiable source yet

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.